undamentalytics Newsletter
Sign in

ResMed| income statement

In fiscal 2026, ResMed| reported revenue of $5.65bn, up 9.9% on the year before, operating income of $1.89bn (a 33.4% margin) and net income of $1.52bn, or $10.43 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Jun 20102011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Jun 20222023Jun 20232024Jun 20242025Jun 20252026Jun 2026LTMSept 2026
Revenue1,0921,2431,3691,5141,5551,6791,8392,0672,3402,6072,9573,1973,5784,2234,6855,1465,6535,733
Cost of revenue———————8651,0051,1131,2391,3581,5541,8672,0302,0912,2022,231
Gross profit6557418219419901,0111,0661,2021,3351,4941,7181,8392,0242,3562,6553,0553,4523,501
Research and development7592110120118115119144155181202225254288308331378394
Selling, general and administrative3293724034314504794885546006456776707388749179931,1201,175
Operating income2402672943554054094294265425798109041,0001,1321,3201,6851,8871,893
Interest expense325666112828364024——————
Net interest income——————————−39−24−22−47————
Income before tax2613043323854314364404195215197338849601,1021,2651,6781,9192,012
Income tax7177777886838776206114111409181204244277396419
Net income1902272553073453533523423164056224757798981,0211,4011,5231,593
Diluted EPS$1.23$1.44$1.71$2.10$2.39$2.47$2.49$2.40$2.19$2.80$4.27$3.24$5.30$6.09$6.92$9.51$10.43$10.97
Diluted shares (average)155m157m149m146m144m143m142m142m144m144m146m—147m147m148m147m146m145m
EBITDA3023383804334794825165386627309651,0601,1601,2971,4971,8842,0882,089

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: RMD vs STEBLCO vs RMDDXCM vs RMDEW vs RMD

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from ResMed|'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to ResMed|.